Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, announced physicians will now have access to advanced new 3D image guidance capabilities through its Image-Guided Therapy Mobile C-arm System - Zenition, delivering enhanced clinical accuracy and efficiency, and aiming to improve the outcomes for patients undergoing endovascular treatment. 
CliniSys is announcing the recent acquisition of HORIZON Lab Systems and the combination with Sunquest Information Systems, as CliniSys. This acquisition and Sunquest combination creates one of the world’s largest organisations dedicated to diagnostic and laboratory informatics. 
Mjog by Livi has launched a remote monitoring tool that will help GPs support and monitor people with depression through messages sent to their smartphones.
The latest data from the Office of National Statistics (ONS) found that 1 in 5 British adults experienced some form of depression in the first quarter of 2021, compared to 1 in ten before the pandemic.
A consortium of NHS trusts that covers a population of circa 1.2 million will gain immediate access to important patient imaging, and will mobilise a regional workforce for patients, following a decision to procure a medical imaging system from Sectra.
Everything from x-rays to ultrasounds, CT scans, MRIs and more will become instantly available to relevant healthcare professions across five trusts in Surrey and Sussex, regardless of where in the consortium a patient has had their medical imaging captured.
Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced it has signed a 12-year strategic partnership with IJsselland Hospital (Capelle aan den Ijssel, The Netherlands). As the hospital's strategic technology partner, Philips will target improved care for patients and care providers at IJsselland Hospital and in the surrounding region. 
Oracle Corporation (NYSE: ORCL) and Cerner Corporation jointly announced an agreement for Oracle to acquire Cerner through an all-cash tender offer for $95.00 per share, or approximately $28.3 billion in equity value. Cerner is a leading provider of digital information systems used within hospitals and health systems to enable medical professionals to deliver better healthcare to individual patients and communities. 
The first patients were recently enrolled in the FAST III trial at the Erasmus University Medical Center in Rotterdam, The Netherlands. This officially marked the beginning of a multicenter, randomized-controlled, open-label study in which the outcome of therapy for coronary artery disease is being investigated after fractional flow reserve (FFR) has been determined using different methods.